Dexamethasone
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Dexamethasone is a potent, long-acting synthetic glucocorticoid with approximately 25–30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid activity. It is used for cerebral edema, severe allergic reactions, chemotherapy-induced nausea, as part of COVID-19 treatment protocols, adrenal insufficiency testing, and numerous other inflammatory and autoimmune conditions.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Dexamethasone is a potent, long-acting synthetic glucocorticoid with approximately 25–30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid activity. NutriStack rates the supporting evidence as strong. Common adult dosing is 0.5–20 mg daily depending on indication; cerebral edema: 10–20 mg IV then 4 mg q6h; COVID-19: 6 mg daily for 10 days (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete calcium, vitamin d, potassium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: most potent commonly used oral corticosteroid, long duration of action permits once-daily dosing, minimal mineralocorticoid effect (less fluid retention). 10 sources indexed (2024–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to glucocorticoid receptors with high affinity. The receptor-drug complex translocates to the nucleus and modulates transcription of hundreds of genes, suppressing inflammatory pathways including NF-kB and AP-1. Inhibits prostaglandin synthesis, reduces pro-inflammatory cytokine production, stabilizes endothelial cell junctions (reducing edema), and profoundly suppresses immune cell function. Its long biological half-life allows once-daily or alternate-day dosing.7
Dosing & protocol.
Take with food to reduce GI upset. Morning dosing preferred to approximate diurnal cortisol pattern.2,8
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Calcium
SignificantGlucocorticoids reduce intestinal calcium absorption, increase urinary calcium loss, and accelerate bone resorption.
Vitamin D
ModerateGlucocorticoids impair activation and signaling of vitamin D, reducing calcium absorption and bone support.
Potassium
ModerateSystemic corticosteroids can promote potassium loss or shifts in susceptible patients, especially at higher doses or with other hypokalemia risks; replacement should be lab-guided.
Magnesium
ModerateChronic corticosteroid use can increase urinary magnesium losses and worsen low magnesium status.
Full safety detail.
Side effects
- Hyperglycemia (more pronounced than other corticosteroids)
- Insomnia and psychiatric effects (agitation, psychosis at high doses)
- Immunosuppression and increased infection risk
- Muscle weakness and proximal myopathy
- Osteoporosis and avascular necrosis
- Cushing syndrome with chronic use
- Adrenal suppression
- Peptic ulcer disease
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Efficacy of different routes of dexamethasone administration for preventing rebound pain following peripheral nerve blocks in adult surgical patients: a systematic review and network meta-analysisPMIDMakkar JK, Singh NP, Khurana BJK et al. · Anaesthesia · 2025
Makkar JK, Singh NP, Khurana BJK et al.. Efficacy of different routes of dexamethasone administration for preventing rebound pain following peripheral nerve blocks in adult surgical patients: a systematic review and network meta-analysis. Anaesthesia. 2025
- 2Dose-response relationships of intravenous and perineural dexamethasone as adjuvants to peripheral nerve blocks: a systematic review and model-based network meta-analysisPMIDZufferey PJ, Chaux R, Lachaud PA et al. · British journal of anaesthesia · 2024
Zufferey PJ, Chaux R, Lachaud PA et al.. Dose-response relationships of intravenous and perineural dexamethasone as adjuvants to peripheral nerve blocks: a systematic review and model-based network meta-analysis. British journal of anaesthesia. 2024
- 3Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysisPMIDCosta BA, Costa TA, Saravia SD et al. · American journal of hematology · 2024
Costa BA, Costa TA, Saravia SD et al.. Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis. American journal of hematology. 2024
- 4Prophylactic dexamethasone for rebound pain after peripheral nerve block in adult surgical patients: systematic review, meta-analysis, and trial sequential analysis of randomised controlled trialsPMIDSingh NP, Makkar JK, Chawla JK et al. · British journal of anaesthesia · 2024
Singh NP, Makkar JK, Chawla JK et al.. Prophylactic dexamethasone for rebound pain after peripheral nerve block in adult surgical patients: systematic review, meta-analysis, and trial sequential analysis of randomised controlled trials. British journal of anaesthesia. 2024
- 5Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysisPMIDCosta BA, Costa TA, Pak K et al. · American journal of hematology · 2024
Costa BA, Costa TA, Pak K et al.. Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis. American journal of hematology. 2024
Reference material
5- 6RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693-704.Source linkedPMID
- 7Rhen T, Cidlowski JA. Anti-inflammatory action of glucocorticoids, new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711-1723.Source linkedPMID
- 8Vecht CJ et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors. J Neurooncol. 1994;22(3):261-269.Source linkedPMID
- 9Dahan E, El Ghazal N, Nakanishi H et al.. Dexamethasone versus prednisone/prednisolone in the management of pediatric patients with acute asthmatic exacerbations: a systematic review and meta-analysis. The Journal of asthma : official journal of the Association for the Care of Asthma. 2023Source linkedPMID
- 10Jones IA, LoBasso MA, Wier J et al.. Perioperative Dexamethasone in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials. Anesthesia and analgesia. 2024Source linkedPMID
Common questions.
Quick answers about Dexamethasone, drawn from the data on this page.
What is Dexamethasone?
Dexamethasone is a potent, long-acting synthetic glucocorticoid with approximately 25–30 times the anti-inflammatory potency of hydrocortisone and virtually no mineralocorticoid activity. It is used for cerebral edema, severe allergic reactions, chemotherapy-induced nausea, as part of COVID-19 treatment protocols, adrenal insufficiency testing, and numerous other inflammatory and autoimmune conditions.
What is Dexamethasone used for?
Commonly cited benefits of Dexamethasone include: Most potent commonly used oral corticosteroid; Long duration of action permits once-daily dosing; Minimal mineralocorticoid effect (less fluid retention); Proven mortality benefit in COVID-19 (RECOVERY trial); Effective anti-emetic in chemotherapy regimens. NutriStack rates the overall evidence as strong.
What is a typical dose of Dexamethasone?
A typical adult dose of Dexamethasone is 0.5–20 mg daily depending on indication; cerebral edema: 10–20 mg IV then 4 mg q6h; COVID-19: 6 mg daily for 10 days (as prescribed by your physician). The commonly recommended form is Oral tablet, oral elixir, IV injection, or IM injection. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Dexamethasone?
Reported side effects include hyperglycemia (more pronounced than other corticosteroids), insomnia and psychiatric effects (agitation, psychosis at high doses), immunosuppression and increased infection risk, muscle weakness and proximal myopathy, osteoporosis and avascular necrosis, cushing syndrome with chronic use. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Dexamethasone?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Dexamethasone in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.